Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1413 of 5804
-
New online therapy aims to help teens manage emotions and reduce mental health symptoms
Symptom relief Recruiting nowMental health problems in youth are a global problem, causing incalculable suffering in youth and families, harming long-term prospects of youths, and creating substantial economic costs to society. The overall objective of this study is to build an evidence base for a highly sc…
Phase: NA • Sponsor: Karolinska Institutet • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
Could a pill replace IV therapy for MDS? new study investigates
Disease control OngoingThis is an Open-Label, Crossover, Pharmacokinetic and Efficacy Bridging Study of Oral ASTX727 versus IV Decitabine in Chinese Subjects with Myelodysplastic Syndromes
Phase: PHASE1, PHASE2 • Sponsor: Otsuka Beijing Research Institute • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Powered arm brace could give SCI patients a helping hand
Symptom relief Recruiting nowTo evaluate the usefulness of an upper extremity assistive device, called (MyoPro) in improving upper extremity activities in people with incomplete spinal cord injury. The Department of Defense is supporting this study.
Phase: NA • Sponsor: Kessler Foundation • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
Mind over shoulder: can imagery training ease chronic pain?
Symptom relief CompletedGraded motor imagery (GMI): used successfully in chronic, complex and painful clinical conditions accompanied by many pain and movement problems; It is a treatment, education and rehabilitation process that is based on recently obtained scientific data and current clinical studie…
Phase: NA • Sponsor: Nuray Alaca • Aim: Symptom relief
Last updated Jul 26, 2026 00:00 UTC
-
New drug cocktail shows promise for Tough-to-Treat colon cancer
Disease control Recruiting nowThis study is being done to see if combining liposomal irinotecan with TAS102 and bevacizumab confers clinical benefit for patients with treatment refractory metastatic colorectal cancer.
Phase: PHASE2 • Sponsor: University of Wisconsin, Madison • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Early treatment may stop swelling in head and neck cancer survivors
Prevention ENROLLING_BY_INVITATIONThe goal of this clinical trial is to learn if treating the lymphatics in head and neck cancer survivors before clinical diagnosis of lymphedema will prevent its development or progression. The main questions it aims to answer are: * Does early lymphatic treatment, before onset …
Phase: PHASE1 • Sponsor: The University of Texas Health Science Center, Houston • Aim: Prevention
Last updated Jun 26, 2026 14:37 UTC
-
Hypnosis during surgery slashes opioid need, new trial shows
Symptom relief Recruiting nowTo hypnosedation alone given before and during surgery on reducing opioid use after surgery compared to standard general anesthesia given alone or with hypnosedation.
Phase: PHASE2, PHASE3 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
Heart valve surgery study tracks patient survival over a decade
Disease control Recruiting nowThis standardized prospective long-term outcome analysis will help reaffirm these findings via a multicenter patient cohort and describe the best practices/techniques for stabilization of the autograft and right ventricular outflow tract reconstruction.
Sponsor: Baylor Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New study aims to cut surgery risks by tracking anesthesia levels
Disease control Recruiting nowIntraoperative hypotension is a common situation. It increases postoperative morbidity and mortality, especially in patients at high postoperative risk undergoing high-risk surgery. Intraoperative hypotension is partly related to anesthesia, and mainly to the combined, dose-depen…
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Saint Etienne • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New drug TISA-818 shows promise for ARDS in early trial
Disease control CompletedThis is a randomized, double-blind, placebo-controlled Phase II clinical study of TISA-818-Inj in patients with ARDS to evaluate the safety, preliminary efficacy, and population PK (Pop PK) profile of TISA-818-Inj in adult ARDS patients. Totally 60 subjects with ARDS are planned…
Phase: PHASE2 • Sponsor: EnliTISA (Shanghai) Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New pill could tame hormone disorder Cushing's syndrome
Disease control Recruiting nowA Phase 1b/2a, first-in-disease, open-label, multiple-ascending dose exploratory study to evaluate safety, tolerability, pharmacokinetics (PK), and pharmacodynamic biomarker responses associated with CRN04894 (an adrenocorticotropic hormone \[ACTH\] receptor antagonist) in partic…
Phase: PHASE1, PHASE2 • Sponsor: Crinetics Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Brain 'Firmness' test may spot Alzheimer's early
Diagnosis ENROLLING_BY_INVITATIONThe purpose of this research is to further investigate the potential of brain stiffness as a novel biomarker for Alzheimer's disease.
Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Jun 27, 2026 08:10 UTC
-
New combo training shows promise for stroke arm recovery
Symptom relief Recruiting nowBackground: Most patients suffer from post-stroke somatosensory and motor impairments, and 50% to 70% of patients in the chronic stage still have upper extremity impairments that severely limit their functional independence and quality of life. Somatosensory and motor functions a…
Phase: NA • Sponsor: National Taiwan University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
Liver cancer drug combo put to the test – but trial stops early
Disease control TerminatedREPLACE is a phase III, multicenter, randomized, open-label trial to evaluate the efficacy and safety of regorafenib and pembrolizumab (Rego-Pembro) versus transarterial chemoembolization (TACE) or transarterial radioembolization (TARE) for the first-line treatment of hepatocellu…
Phase: PHASE3 • Sponsor: Translational Research in Oncology • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New study aims to find best Pre-Surgery hormone treatment for men with breast cancer
Disease control Recruiting nowThis research study is looking to see how well male breast cancer responds to preoperative treatment with endocrine therapy and which endocrine therapy regimen is the most effective treatment for male breast cancer. The drugs used in this study are: * Tamoxifen * Anastrozole * …
Phase: PHASE2 • Sponsor: Jose Pablo Leone • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Oxygen showdown: can high flow save more lives in east africa?
Disease control Recruiting nowAcute hypoxemia is common and deadly in resource variable settings. While studies in high income countries (HICs) have indicated a possible benefit to high flow oxygen as compared with standard flow oxygen, rigorous studies in low or lower middle income countries (LMICs) have not…
Phase: NA • Sponsor: Beth Israel Deaconess Medical Center • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New targeted pill shows promise for rare bile duct cancer in small trial
Disease control OngoingThis study will enroll participants with nonresectable or metastatic cholangiocarcinoma with an Isocitrate dehydrogenase protein, 1 (IDH1) mutation, who have previously received at least 1, but no more than 2, prior regimens for advanced disease. All participants will receive ivo…
Phase: PHASE2 • Sponsor: Servier • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Beat the odds: new device uses music to retrain stroke Patients' gait
Disease control CompletedThe purpose of this trial is to assess engagement, efficacy, durability, and impact on health care resource utilization of MR-001 in persons with chronic stroke who have a gait deficit after in-home/community use.
Phase: NA • Sponsor: MedRhythms, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
New heart pacing technique could help when standard therapy fails
Disease control Recruiting nowWhile cardiac resynchronization therapy remains the mainstay for advanced HF, it is not always feasible due to unfavorable anatomy of coronary sinus or pacing characteristics. In such cases, left bundle branch area pacing itself or left bundle optimized cardiac resynchronization …
Sponsor: Seoul National University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New nasal nerve device shows promise for stuffy noses
Symptom relief CompletedThe NEUROMARK RCT Study is a prospective, multicenter, randomized, sham-controlled, single-blinded, superiority trial.
Phase: NA • Sponsor: Neurent Medical • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC